<DOC>
	<DOCNO>NCT00390039</DOCNO>
	<brief_summary>Multiple-center , multiple-dose , randomize , double-blind , six-arm , active- placebo-controlled study patient moderate severe post-surgical pain elective orthopedic surgery safety observe total 30 hour post first dose .</brief_summary>
	<brief_title>Efficacy Safety Intranasal Morphine Pain After Elective Orthopedic Surgery</brief_title>
	<detailed_description>Multiple-center , multiple-dose , randomize , double-blind , six-arm , active- placebo-controlled study repeat intermittent PRN dose 24 hour Intranasal ( IN ) Morphine Nasal Spray ( MNS075 ) 7.5 mg 15 mg , 7.5 mg IV morphine infusion placebo ( either IN IV ) , patient moderate severe post-surgical pain elective orthopedic surgery safety observe total 30 hour post first dose .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Over 18 year old Scheduled ( within two week screen visit ) undergo elective orthopedic surgery ( e.g. , bunionectomy , arthroscopic knee surgery , rotator cuff repair ) Moderate severe pain within 8 hour follow completion require surgery Previous anaphylactic serious allergic reaction shellfish opioids History sleep apnea Other Inclusion/Exclusion Criteria May Apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Pain , postoperative</keyword>
	<keyword>Surgery , orthopedic</keyword>
	<keyword>Morphine</keyword>
</DOC>